This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Idexx Laboratories (IDXX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 279.06M 223.99M 183.90M 156.92M
Receivables 158.04M 138.32M 141.28M 120.08M
Inventories 133.43M 140.95M 133.10M 127.88M
Other Current Assets 48.96M 38.57M 40.32M 29.51M
Total Current Assets 652.71M 569.54M 524.23M 460.59M
Property, Plant & Equipment, Gross 550.02M 478.31M 422.35M 376.62M
Accumulated Depreciation & Depletion 268.80M 233.13M 205.57M 174.90M
Property, Plant & Equipment, Net 281.21M 245.18M 216.78M 201.72M
Intangibles 58.84M 62.83M 69.21M 55.75M
Other Non-Current Assets 57.23M 51.06M 47.99M 29.33M
Total Non-Current Assets 577.81M 534.06M 506.59M 436.55M
Liabilities & Shareholder Equity
Total Assets 1.23B 1.10B 1.03B 897.14M
Accounts Payable 29.94M 35.29M 36.55M 22.67M
Short Term Debt 278.04M 213.11M 243.92M 129.86M
Other Current Liabilities 16.51M 0.00 0.00 12.32M
Total Current Liabilities 478.35M 406.33M 436.88M 285.11M
Long Term Debt 150.36M 1.39M 2.50M 3.42M
Deferred Income Taxes 33.95M 23.03M 23.29M 18.66M
Other Non-Current Liabilities 49.64M 36.59M 28.55M 15.67M
Minority Interest -6.00K 20.00K -32.00K 36.00K
Total Non-Current Liabilities 233.98M 61.05M 54.36M 37.80M
Total Liabilities 712.33M 467.38M 491.24M 322.91M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 518.19M 636.22M 539.58M 574.24M
Common Par 10.12M 10.02M 9.92M 9.80M
Additional Paid In Capital 825.32M 757.21M 702.58M 641.64M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 1.49B 1.31B 1.13B 965.54M
Treasury Stock -1.83B -1.46B -1.32B -1.06B
Other Equity Adjustments 18.73M 20.58M 20.13M 17.90M
Total Capitalization 668.54M 637.62M 542.08M 577.65M
Total Equity 518.19M 636.22M 539.58M 574.24M
Total Liabilities & Stock Equity 1.23B 1.10B 1.03B 897.14M
Total Common Shares Outstanding 51.66M 54.51M 55.10M 57.31M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 49.65M 45.65M 44.13M 40.66M
Basic Weighted Shares Outstanding 53.16M 54.98M 56.79M 57.71M
Diluted Weighted Shares Outstanding 53.98M 56.16M 58.21M 59.56M
Number of Employees 5700 5400 5100 4800
Number of Part-Time Employees 0 0 0 0

IDXX Idexx Laboratories

Analysts Ratings for IDXX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 4 4
Moderate Buy 1 1 1 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 2 2 2 2

Brokerage Partners

IDXX Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs